Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. Its pipeline includes programs targeting KIT-driven diseases and other areas of unmet medical need.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!